$144.01 +1.62 (%) Amgen Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Guide to American Funds Investment Company of America R2 Fund (RICBX)

    TalkMarkets | Dec. 4, 2016 | 04:08AM EST
  2. Amgen, Regeneron 2017 LDL-Busters Could Boost This Small-Cap Biotech

    Investors Business Daily | Dec. 2, 2016 | 13:57PM EST
  3. Here's How Much Trump Tax Cuts Could Boost The Stock Market

    Investors Business Daily | Dec. 2, 2016 | 13:52PM EST
  4. Bluebird Rockets On Myeloma Drug; Celgene Gets Boost

    Investors Business Daily | Dec. 1, 2016 | 12:10PM EST
  5. Bluebird Bio, Celgene Multiple Myeloma Therapy Shines In 9-Patient Study

    Investors Business Daily | Nov. 30, 2016 | 18:58PM EST
  6. TalkMarkets Presents: Ranjit Thomas - An Overview Of Recent Earnings And Resulting Stock Ideas

    TalkMarkets | Nov. 28, 2016 | 15:37PM EST
  7. 6 Worthy Dividend Stocks Down 10% Or More

    TalkMarkets | Nov. 24, 2016 | 03:57AM EST
  8. Morning Call For Thursday, Nov. 17

    TalkMarkets | Nov. 17, 2016 | 09:01AM EST
  9. Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved

    TalkMarkets | Nov. 16, 2016 | 15:30PM EST
  10. Stock Exchange: Is Technical Analysis Effective Post-Election?

    TalkMarkets | Nov. 10, 2016 | 22:46PM EST
  11. Stocks Going Ex Dividend The Third Week Of November

    TalkMarkets | Nov. 10, 2016 | 04:57AM EST
  12. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets | Nov. 9, 2016 | 23:23PM EST
  13. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets | Nov. 7, 2016 | 10:20AM EST
  14. Before The Move: Stocks To Own If Trump Wins

    TalkMarkets | Nov. 6, 2016 | 16:47PM EST
  15. Pricing Issues Continue To Weigh On The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 20:01PM EST
  16. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 18:49PM EST
  17. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  18. Why After A Massive Run, CoLucid Shares Still Look Attractive

    TalkMarkets | Oct. 31, 2016 | 09:02AM EST
  19. The U.S. Economy Grew At Its Fastest Pace In Two Years

    TalkMarkets | Oct. 29, 2016 | 09:34AM EST
  20. AskSlim Market Week - 10/28/16

    TalkMarkets | Oct. 28, 2016 | 22:00PM EST
  21. Gilead Sciences, Inc.: Why You Should Go Long On Gilead Stock?

    TalkMarkets | Oct. 28, 2016 | 15:30PM EST
  22. 5 Stocks To Watch After The Market Closes Today - October 27, 2016

    TalkMarkets | Oct. 27, 2016 | 08:52AM EST
  23. 5 Stocks To Watch After The Market Closes Today, 10/27/16

    TalkMarkets | Oct. 27, 2016 | 08:52AM EST
  24. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets | Oct. 26, 2016 | 20:45PM EST
  25. Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates

    TalkMarkets | Oct. 26, 2016 | 14:15PM EST
  26. 5 Healthcare Stocks To Buy Despite A Clinton Victory

    TalkMarkets | Oct. 25, 2016 | 14:07PM EST
  27. Novartis Tops Q3 Earnings, Misses Sales Estimates

    TalkMarkets | Oct. 25, 2016 | 12:47PM EST
  28. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets | Oct. 20, 2016 | 13:53PM EST
  29. Swing Trading Watch List - October 11, 2016

    TalkMarkets | Oct. 11, 2016 | 22:19PM EST
  30. Earnings ESP

    TalkMarkets | Oct. 8, 2016 | 18:11PM EST
  31. Rayno 2016 Life Science Portfolio Update

    TalkMarkets | Sep. 29, 2016 | 20:14PM EST
  32. Ligand Pharma Dives After Out-Licensed Drug Misses Study Goal

    TalkMarkets | Sep. 27, 2016 | 22:10PM EST
  33. Amgen's Multiple Myeloma Drug Bumbles Key Test Vs. Blockbuster Velcade

    IBD | Sep. 27, 2016 | 15:23PM EST
  34. Biosimilars In Limelight On FDA Approval Of Amgen Drug

    TalkMarkets | Sep. 27, 2016 | 12:30PM EST
  35. Stocks Extend Gains; Facebook Up On Positive Analyst Chatter

    IBD | Sep. 27, 2016 | 11:40AM EST
  36. Stocks Up After 1st Presidential Debate; Why Tesla Looks Healthiest In Weeks

    IBD | Sep. 27, 2016 | 10:38AM EST
  37. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets | Sep. 22, 2016 | 20:00PM EST
  38. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?

    Investors Business Daily | Aug. 2, 2016 | 15:09PM EST
  39. QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To $40

    Investors Business Daily | Aug. 1, 2016 | 17:08PM EST
  40. What's Driving The Biotech Stock Rally? And Will It Last?

    Investors Business Daily | Aug. 1, 2016 | 14:15PM EST
  41. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names

    Investors Business Daily | Aug. 1, 2016 | 11:20AM EST
  42. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 11:13AM EST
  43. Amgen Beats Q2 Earnings Estimates, Raises Guidance

    Investors Business Daily | Jul. 27, 2016 | 15:28PM EST
  44. Facebook, GoPro, Amgen Beat; Whole Foods Disappoints

    Investors Business Daily | Jul. 27, 2016 | 15:20PM EST
  45. Nasdaq Up As Fed Stands Pat On Rates; Will Apple Break Its Downtrend?

    Investors Business Daily | Jul. 27, 2016 | 13:17PM EST
  46. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily | Jul. 25, 2016 | 10:05AM EST
  47. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles

    Investors Business Daily | Jul. 25, 2016 | 04:00AM EST
  48. Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, M&A News

    Investors Business Daily | Jul. 22, 2016 | 11:25AM EST
  49. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  50. Chardan Upgrades Regeneron Amid Relative Underperformance To Amgen Shares

    Benzinga | Feb. 16, 2016 | 08:33AM EST
Trading Center